Showing results (101-110 of 154) with videos related to
Sort By:
Pageof 16
Cancer|December 15, 1989
High levels of doxorubicin in the tissues of a patient experiencing extravasation during a 4-day infusionR T Dorr, M S Dordal, L M Koenig, et al.Journal of Medicinal Chemistry|December 6, 1996
2-[2'-(Dimethylamino)ethyl]-1,2-dihydro- 3H-dibenz[de,h]isoquinoline-1,3-diones with substituents at positions 4, 8, 9, 10, and 11. Synthesis, antitumor activity, and quantitative structure-activity relationshipsS M Sami, R T Dorr, D S Alberts, et al.Cancer Treatment Reports|July 1, 1985
Methotrexate: bioavailability and pharmacokineticsM A Campbell, D G Perrier, R T Dorr, et al.Journal of Medicinal Chemistry|August 24, 2000
Analogues of amonafide and azonafide with novel ring systemsS M Sami, R T Dorr, D S Alberts, et al.Cancer Research|January 15, 1989
Antitumor activity and murine pharmacokinetics of parenteral acronycineR T Dorr, J D Liddil, D D Von Hoff, et al.Bone Marrow Transplantation|April 15, 2003
Comparative pharmacokinetic study of high-dose etoposide and etoposide phosphate in patients with lymphoid malignancy receiving autologous stem cell transplantationR T Dorr, A Briggs, P Kintzel, et al.Journal of Medicinal Chemistry|July 1, 1991
Structure-activity relationships for mitomycin C and mitomycin A analoguesK R Kunz, B S Iyengar, R T Dorr, et al.Journal of Medicinal Chemistry|March 17, 1995
Amino-substituted 2-[2'-(dimethylamino)ethyl]-1,2-dihydro-3H- dibenz[de,h]isoquinoline-1,3-diones. Synthesis, antitumor activity, and quantitative structure--activity relationshipS M Sami, R T Dorr, A M Sólyom, et al.Cell Death and Differentiation|January 1, 1996
Modulation of the antioxidant defence as a factor in apoptosisM M Briehl, A F BakerInvestigational New Drugs|January 1, 1996
Antitumor activity of combretastatin-A4 phosphate, a natural product tubulin inhibitorR T Dorr, K Dvorakova, K Snead, et al.Pageof 16